Tildacerfont

Unknown Manufacturer

Tildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring

Overview

Tildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

TILDACERFONT AND DERIVATIVES THEREOF FOR TREATING POLYCYSTIC OVARY SYNDROME
EP 4656192 A3Applicant: SPRUCE BIOSCIENCES INCPriority: 2020
EP
Crystalline composition of tildacerfont and methods of use and preparation thereof
- US 11708372 B2
  Applicant: SPRUCE BIOSCIENCES INCPriority: 2022
  US
- US 2024293421 A1
  Applicant: SPRUCE BIOSCIENCES INCPriority: 2024
  US
CRYSTALLINE COMPOSITIONS OF TILDACERFONT AND METHODS OF USE AND PREPARATION THEREOF
CN 118574833 AApplicant: SPRUCE BIOSCIENCES INCPriority: 2022
CN
TILDACERFONT COCRYSTAL FORMULATIONS
WO 2024243431 A1Applicant: SPRUCE BIOSCIENCES INCPriority: 2023
WO
AMORPHOUS SOLID DISPERSION OF TILDACERFONT FORMULATIONS
WO 2025188842 A8Applicant: SPRUCE BIOSCIENCES INCPriority: 2024
WO